Tag: FDA

Air pollution, FDA on food dyes, measles update

The lack of air quality monitoring in these rural areas is concerning, as it leaves millions of Americans

FDA to remove pharma, industry employees from advisory panels

The Food and Drug Administration (FDA) is making a significant change to its advisory committees by removing industry

Harvard, Supreme Court, FDA, PTSD

approves AstraZeneca COVID-19 vaccine for emergency use, Reuters Measles cases in U.S. reach record high since elimination, CDC

Trial of pig livers as dialysis-like treatment for liver failure cleared by FDA

A groundbreaking clinical trial is set to take place in the U.S. as researchers prepare to test the

FDA layoffs expected to slow down crucial drug reviews

The Trump administration's decision to fire thousands of Food and Drug Administration (FDA) employees had a significant impact

NIH, FDA, autism, excessive sleepiness

“Clinicians should take a proactive approach to identifying and treating sleepiness, which can have a profound impact on

RFK Jr. speech to FDA workers on MAHA agenda, chronic diseases

Robert F. Kennedy Jr. delivered a captivating speech to Food and Drug Administration employees in Washington, DC, urging

RFK Jr. and vaccines, FDA drug reviews threatened

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up

Judge strikes down FDA lab-developed test rule

A federal judge in Texas has made a significant ruling against the Food and Drug Administration (FDA) regarding

HHS cuts to include 3,500 FDA layoffs, workers to be notified Friday

The Food and Drug Administration (FDA) is facing significant layoffs as part of a larger restructuring plan by

At FDA two top cancer regulators to depart

Two deputy directors at the Food and Drug Administration (FDA) who oversee the regulation of cancer drugs are

Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs

Americans are facing exorbitant prices for prescription drugs, leading to the U.S. accounting for half of global pharmaceutical